STERIS plc — Director's Dealing 2022

Jun 3, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STERIS plc (STE)
CIK: 0001757898
Period of Report: 2022-06-01

Reporting Person: Madsen Julia (Senior VP, Life Sciences)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-01	Ordinary Shares	F	42	$221.46	Disposed	6198	Direct
2022-06-02	Ordinary Shares	A	1408	$0.00	Acquired	7606	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-02	Employee Stock Options (right to buy)	$250.06	A	6404	Acquired	2032-06-02	Ordinary Shares (6404)	Direct

Footnotes

F1: 42 shares were withheld from the 123 restricted shares that vested on June 1, 2022. These 42 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 123 ordinary shares were awarded to Ms. Madsen on June 1, 2020. These vested shares were valued at the NYSE closing market price on June 1, 2022.

F2: As of June 2, 2022, 4,809 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 360 on June 2, 2022; 349 on October 3, 2022; 144 on October 3, 2022; 92 on May 31, 2023; 123 on June 1, 2023; 352 on June 2, 2023; 360 on June 2, 2023; 349 on October 2, 2023; 144 on October 2, 2023; 352 on June 3, 2024; 123 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 352 on June 2, 2025; 360 on June 2, 2025; 144 on October 1, 2025 and 352 on June 2, 2026.

F3: This option becomes exercisable as follows: 1,601 on June 2, 2023, 1,601 on June 3, 2024, 1,601 on June 2, 2025 and 1,601 on June 2, 2026